{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T20:12:20Z","timestamp":1787602340066,"version":"build-2736575974"},"reference-count":29,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,5]],"date-time":"2024-01-05T00:00:00Z","timestamp":1704412800000},"content-version":"am","delay-in-days":338,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["amjmedsci.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of the Medical Sciences"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.amjms.2022.08.019","type":"journal-article","created":{"date-parts":[[2022,9,7]],"date-time":"2022-09-07T02:26:50Z","timestamp":1662517610000},"page":"189-197","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Fibroblast-derived conditioned media promotes lung cancer progression"],"prefix":"10.1016","volume":"365","author":[{"given":"John C.","family":"Greenwell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edilson","family":"Torres-Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey D.","family":"Ritzenthaler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesse","family":"Roman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjms.2022.08.019_bib0001","first-page":"5","article-title":"Cancer statistics, 2015","volume":"65","author":"Siegel","year":"2015","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.amjms.2022.08.019_bib0002","series-title":"Food, Nutrition, Physical Activity, and the Prevention of Cancer: a Global Perspective","year":"2007"},{"key":"10.1016\/j.amjms.2022.08.019_bib0003","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1093\/jnci\/91.14.1194","article-title":"Tobacco smoke carcinogen and lung cancer","volume":"91","author":"Hecht","year":"1999","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.amjms.2022.08.019_bib0004","first-page":"4217","article-title":"The multistep nature of cancer development","volume":"44","author":"Farber","year":"1984","journal-title":"Cancer Res"},{"key":"10.1016\/j.amjms.2022.08.019_bib0005","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1158\/0008-5472.CAN-05-2521","article-title":"Multiple oncogenic changes (K-RAS(V12), p53 knockdown, mutant EGFRs, p16 bypass, telomerase) are not sufficient to confer a full malignant phenotype on human bronchial epithelial cells","volume":"66","author":"Sato","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.amjms.2022.08.019_bib0006","doi-asserted-by":"crossref","first-page":"150","DOI":"10.3322\/canjclin.54.3.150","article-title":"Chemoprevention of cancer","volume":"54","author":"Tsao","year":"2004","journal-title":"A Cancer J Clin"},{"key":"10.1016\/j.amjms.2022.08.019_bib0007","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/87872","article-title":"Molecular targets for breast cancer therapy and prevention","volume":"7","author":"Bange","year":"2001","journal-title":"Nat Med"},{"key":"10.1016\/j.amjms.2022.08.019_bib0008","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0092-8674(94)90187-2","article-title":"The implications of angiogenesis for the biology and therapy of cancer metastasis","volume":"79","author":"Fidler","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.amjms.2022.08.019_bib0009","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1152\/physrev.1996.76.1.69","article-title":"Cellular changes involved in conversion of normal to malignant breast: importance of the stromal reaction","volume":"76","author":"R\u00f8nnov-Jessen","year":"1996","journal-title":"Physiol Rev"},{"key":"10.1016\/j.amjms.2022.08.019_bib0010","first-page":"3791","article-title":"Lewis lung carcinoma progression is facilitated by TIG-3 fibroblast cells","volume":"33","author":"Yamauchi","year":"2013","journal-title":"Anticancer Res"},{"key":"10.1016\/j.amjms.2022.08.019_bib0011","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.athoracsur.2015.05.014","article-title":"Human lung fibroblasts inhibit non-small cell lung cancer metastasis in ex vivo 4D model","volume":"100","author":"Mishra","year":"2015","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.amjms.2022.08.019_bib0012","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12931-017-0604-z","article-title":"Hepatocyte growth factor produced in lung fibroblasts enhances non-small cell lung cancer cell survival and tumor progression","volume":"18","author":"Kanaji","year":"2017","journal-title":"Respir Res"},{"key":"10.1016\/j.amjms.2022.08.019_bib0013","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1093\/carcin\/bgl003","article-title":"Transgenic mice overexpressing hepatocyte growth factor in the airways show increased susceptibility to lung cancer","volume":"27","author":"Stabile","year":"2006","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.amjms.2022.08.019_bib0014","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.ajpath.2012.05.023","article-title":"Dual inhibition of met kinase and angiogenesis to overcome HGF-induced EGFR-TKI resistance in EGFR mutant lung cancer","volume":"181","author":"Takeuchi","year":"2012","journal-title":"Am J Pathol"},{"key":"10.1016\/j.amjms.2022.08.019_bib0015","doi-asserted-by":"crossref","first-page":"9479","DOI":"10.1158\/0008-5472.CAN-08-1643","article-title":"Hepatocyte growth factor induces gefitinib resistance of lung adenocarcinoma with epidermal growth factor receptor-activating mutations","volume":"68","author":"Yano","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.amjms.2022.08.019_bib0016","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12967-015-0588-8","article-title":"MRC-5 fibroblast-conditioned medium influences multiple pathways regulating invasion, migration, proliferation, and apoptosis in hepatocellular carcinoma","volume":"13","author":"Ding","year":"2015","journal-title":"J Transl Med"},{"key":"10.1016\/j.amjms.2022.08.019_bib0017","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ccr.2009.12.041","article-title":"Cancer-associated fibroblasts are activated in incipient neoplasia to orchestrate tumor-promoting inflammation in an NF-??B-dependent manner","volume":"17","author":"Erez","year":"2010","journal-title":"Cancer Cell"},{"key":"10.1016\/j.amjms.2022.08.019_bib0018","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.3390\/cancers7040902","article-title":"Cancer-associated fibroblasts: their characteristics and their roles in tumor growth","volume":"7","author":"Shiga","year":"2015","journal-title":"Cancers"},{"key":"10.1016\/j.amjms.2022.08.019_bib0019","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1242\/jcs.01634","article-title":"Cadherin switching: essential for behavioral but not morphological changes during an epithelium-to-mesenchyme transition","volume":"118","author":"Maeda","year":"2005","journal-title":"J Cell Sci"},{"key":"10.1016\/j.amjms.2022.08.019_bib0020","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1002\/mc.22029","article-title":"Differential effects on lung cancer cell proliferation by agonists of glucocorticoid and PPARa receptors","volume":"53","author":"Liang","year":"2014","journal-title":"Mol Carcinog"},{"key":"10.1016\/j.amjms.2022.08.019_bib0021","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.3892\/etm.2016.3382","article-title":"Differential effects of MTSS1 on invasion and proliferation in subtypes of non-small cell lung cancer cells","volume":"12","author":"Ling","year":"2016","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.amjms.2022.08.019_bib0022","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1021\/cr980421n","article-title":"Structure, recognition, and processing of cisplatin\u00a0\u2212\u00a0DNA adducts","volume":"99","author":"Jamieson","year":"1999","journal-title":"Chem Rev"},{"key":"10.1016\/j.amjms.2022.08.019_bib0023","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s00204-006-0173-2","article-title":"Cisplatin-induced nephrotoxicity is associated with oxidative stress, redox state unbalance, impairment of energetic metabolism and apoptosis in rat kidney mitochondria","volume":"81","author":"Santos","year":"2007","journal-title":"Arch Toxicol"},{"key":"10.1016\/j.amjms.2022.08.019_bib0024","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.4161\/cbt.7.8.6264","article-title":"Differential impact of fibroblasts on the efficient cell death of lung cancer cells induced by paclitaxel and cisplatin","volume":"7","author":"Bartling","year":"2008","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.amjms.2022.08.019_bib0025","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3109\/01902148.2016.1172370","article-title":"Confluence-depenent resistance to cisplatin in lung cancer cells is regulated by transforming growth factor-beta","volume":"42","author":"Yokokura","year":"2016","journal-title":"Exp Lung Res"},{"key":"10.1016\/j.amjms.2022.08.019_bib0026","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1476-4598-4-25","article-title":"Overcoming cisplatin resistance by mTOR inhibitor in lung cancer","volume":"4","author":"Wu","year":"2005","journal-title":"Mol Cancer"},{"key":"10.1016\/j.amjms.2022.08.019_bib0027","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/nrm3012","article-title":"MET signalling: principles and functions in development, organ regeneration and cancer","volume":"11","author":"Trusolino","year":"2010","journal-title":"Nat Rev Mol cell Biol"},{"issue":"4","key":"10.1016\/j.amjms.2022.08.019_bib0028","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1158\/0008-5472.CAN-04-2650","article-title":"Functional expression and mutations of c-Met and its therapeutic inhibition with SU11274 and small interfering RNA in non-small cell lung cancer","volume":"65","author":"Ma","year":"2005","journal-title":"Cancer Res"},{"issue":"9","key":"10.1016\/j.amjms.2022.08.019_bib0029","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1097\/JTO.0b013e3181e2a409","article-title":"Molecular predictors of sensitivity to the MET inhibitor PHA665752 in lung carcinoma cells","volume":"5","author":"Matsubara","year":"2010","journal-title":"J Thorac Oncol"}],"container-title":["The American Journal of the Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962922003767?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962922003767?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T18:42:58Z","timestamp":1757702578000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002962922003767"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["S0002962922003767"],"URL":"https:\/\/doi.org\/10.1016\/j.amjms.2022.08.019","relation":{},"ISSN":["0002-9629"],"issn-type":[{"value":"0002-9629","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fibroblast-derived conditioned media promotes lung cancer progression","name":"articletitle","label":"Article Title"},{"value":"The American Journal of the Medical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjms.2022.08.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Inc. on behalf of Southern Society for Clinical Investigation.","name":"copyright","label":"Copyright"}]}}